Kaupinen Wes - 13 Dec 2024 SCHEDULE 13D Report for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA)

Filing Manager: Kaupinen Wes
Reporting Manager: Kaupinen Wes
Security: PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share
Symbol: PVLA
Shares outstanding: 11,266,226 shares
Disclosed Ownership: 1,644,869 shares
Ownership: 15%
Form type: SCHEDULE 13D
Filing time: 20 Dec 2024, 17:32:09 UTC
Date of event: 13 Dec 2024
SEC: View on sec.gov

Key filing fact

Kaupinen Wes disclosed 15% ownership in PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA) on 13 Dec 2024.

Key facts

Kaupinen Wes filed SCHEDULE 13D for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA).
Disclosed ownership: 15%.
Date of event: 13 Dec 2024.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Kaupinen Wes	15%	1,644,869	82,051	1,562,818	Wesley H. Kaupinen	Wesley H. Kaupinen	0001918142
Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019	6.9%	781,409	0	781,409	Christine L. Kaupinen	Trustee
Christine L. Kaupinen	14%	1,562,818	0	1,562,818	Christine L. Kaupinen	Christine L. Kaupinen
Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019	6.9%	781,409	0	781,409	Michael Christopher	Trustee
Michael Christopher	6.9%	781,409	0	781,409	Michael Christopher	Michael Christopher

CIK / CUSIP context first

Broader feeds